Yueting Technology (Hangzhou) Co., Ltd. – Trademark Portfolio

Entity Type: 99

Yueting Technology (Hangzhou) Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UTEEUP. The owner is based in Zhejiang Province.

Room B1022, 10th Floor, Building B, No. 369, Wulianwang street, Xixing Street, Binjiang District, Hangzhou City,

Zhejiang Province 310000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UTEEUP
UTEEUP
Registered 2025

Trademark Classifications

Yueting Technology (Hangzhou) Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Yueting Technology (Hangzhou) Co., Ltd. have?

Yueting Technology (Hangzhou) Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Yueting Technology (Hangzhou) Co., Ltd. file in?

Yueting Technology (Hangzhou) Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Yueting Technology (Hangzhou) Co., Ltd.'s most well-known trademarks?

Yueting Technology (Hangzhou) Co., Ltd.'s registered trademark portfolio includes well-known marks such as UTEEUP. These are among 1 currently registered trademark in the portfolio.

What is Yueting Technology (Hangzhou) Co., Ltd.'s trademark registration success rate?

Yueting Technology (Hangzhou) Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.